Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Mindset assists those with a mental illness and their caregivers in applying for Social Security Disability benefits.
Abnormal AI is the leading AI-native human behavior security platform.
MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.
Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.
Hyzon Motors is a global supplier of hydrogen fuel-cell powered commercial vehicles.
Scorpion Therapeutics is a clinical-stage oncology company that specializes in precision medicine for cancer patients.
TS Conductor specializes in high-performance conductors that increase the ampacity of electric transmission and distribution.
Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.
GrayMatter Robotics provides AI-powered robotic solutions that enhance productivity and efficiency for high-mix manufacturers.
CARGO Therapeutics develops an adoptive cell therapy to benefit patients from potentially curative treatment options.
Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases.
WeWork is a platform for creators that transforms buildings into dynamic environments for creativity, focus, and collaboration.
Finvero is a fintech company, operating a consumer Lending MarketPlace Platform (SaaS format) connecting merchants, shoppers and lenders.
Arcadia is a climate software and data company that specializes in decarbonizing the electric grid.
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
BetterUp provides AI and human coaching to improve leadership, management, and employee performance across organizations.
Binkey is a financial technology company that helps merchants to accepts FSA and HSA as a form of payment.
Verve Therapeutics is a clinical-stage biotechnology company developing genetic medicines for cardiovascular disease.
Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer.
Caraway is providing college women+ with integrated mental, reproductive, and physical healthcare.
Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma.
Alkeus Pharmaceuticals is a Boston-based startup focused on treatments for serious ophthalmic conditions.
Boundless Bio is a precision oncology company that develops therapeutics directed against extrachromosomal DNA in aggressive cancers.
Clerkie is an AI financial planner that provides financial knowledge, personalized answers, and actionable plans.
Wellington Management has invested in 276 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Wellington Management's top investment sectors include Biotechnology, Health Care, Pharmaceutical, Artificial Intelligence (AI), Therapeutics. The firm invests across 49 different industry categories.
Among tracked funding rounds, WeWork received $450.0M in a Post Ipo Equity round. Wellington Management's total known invested capital is $58.1B.
Wellington Management's average investment size is $261.7M across its portfolio of 276 companies.
Recent Wellington Management portfolio additions include Mindset, Abnormal AI, MBX Biosciences, Day One Biopharmaceuticals, Hyzon Motors. These companies were founded in 2020 or later.